JP2023109969A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023109969A5 JP2023109969A5 JP2023087510A JP2023087510A JP2023109969A5 JP 2023109969 A5 JP2023109969 A5 JP 2023109969A5 JP 2023087510 A JP2023087510 A JP 2023087510A JP 2023087510 A JP2023087510 A JP 2023087510A JP 2023109969 A5 JP2023109969 A5 JP 2023109969A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cbd
- composition according
- effective amount
- per day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 19
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 15
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 15
- 229950011318 cannabidiol Drugs 0.000 claims 14
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 14
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 14
- 208000024891 symptom Diseases 0.000 claims 4
- 208000006820 Arthralgia Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 208000024765 knee pain Diseases 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024197147A JP2025024068A (ja) | 2017-08-14 | 2024-11-12 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762545468P | 2017-08-14 | 2017-08-14 | |
| US62/545,468 | 2017-08-14 | ||
| US201862661733P | 2018-04-24 | 2018-04-24 | |
| US62/661,733 | 2018-04-24 | ||
| JP2020509441A JP2020530857A (ja) | 2017-08-14 | 2018-08-13 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
| PCT/IB2018/056090 WO2019034985A1 (en) | 2017-08-14 | 2018-08-13 | METHODS OF TREATING ARTHROSIS USING CANNABIDIOL TRANSDERMAL GEL |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509441A Division JP2020530857A (ja) | 2017-08-14 | 2018-08-13 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024197147A Division JP2025024068A (ja) | 2017-08-14 | 2024-11-12 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023109969A JP2023109969A (ja) | 2023-08-08 |
| JP2023109969A5 true JP2023109969A5 (https=) | 2023-12-18 |
| JP7590803B2 JP7590803B2 (ja) | 2024-11-27 |
Family
ID=65362584
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509441A Pending JP2020530857A (ja) | 2017-08-14 | 2018-08-13 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
| JP2023087510A Active JP7590803B2 (ja) | 2017-08-14 | 2023-05-29 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
| JP2024197147A Pending JP2025024068A (ja) | 2017-08-14 | 2024-11-12 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509441A Pending JP2020530857A (ja) | 2017-08-14 | 2018-08-13 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024197147A Pending JP2025024068A (ja) | 2017-08-14 | 2024-11-12 | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20200170963A1 (https=) |
| EP (1) | EP3668500A4 (https=) |
| JP (3) | JP2020530857A (https=) |
| KR (1) | KR20200054171A (https=) |
| AU (2) | AU2018318425A1 (https=) |
| BR (1) | BR112020003025A2 (https=) |
| CA (1) | CA3072849A1 (https=) |
| IL (2) | IL301622A (https=) |
| JO (1) | JOP20200031A1 (https=) |
| MX (1) | MX2020001768A (https=) |
| WO (1) | WO2019034985A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020530857A (ja) * | 2017-08-14 | 2020-10-29 | ジナーバ・ファーマシューティカルズ・インコーポレイテッド | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
| CA3300266A1 (en) | 2017-09-28 | 2026-03-02 | Harmony Biosciences Management, Inc. | Treatment of fragile x syndrome with cannabidiol |
| US12582664B2 (en) | 2017-09-28 | 2026-03-24 | Harmony Biosciences Management, Inc. | Treatment of fragile x syndrome with cannabidiol |
| CA3122735A1 (en) | 2018-12-14 | 2020-06-18 | Zynerba Pharmaceuticals, Inc. | Treatment of 22q11.2 deletion syndrome with cannabidiol |
| US12409131B2 (en) | 2019-10-03 | 2025-09-09 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| AU2020358869A1 (en) | 2019-10-03 | 2022-04-14 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| US12016829B2 (en) | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| EP4041209A4 (en) | 2019-10-11 | 2024-01-24 | Pike Therapeutics, Inc. | TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS |
| EP4041210B1 (en) * | 2019-10-13 | 2026-03-18 | FibroBiologics, Inc. | Combination of cannabidiol and fibroblasts for use in the treatment of disc degenerative disease |
| US12121617B2 (en) | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| US12268699B2 (en) | 2019-10-14 | 2025-04-08 | Pike Therapeutics Inc. | Transdermal delivery of tetrahydrocannabinol |
| CA3155181A1 (en) | 2019-10-14 | 2021-04-22 | Pike Therapeutics, Inc., 1219014 B.C. Ltd. | Transdermal delivery of cannabidiol |
| BR112022026044A2 (pt) * | 2020-06-29 | 2023-03-07 | Zynerba Pharmaceuticals Inc | Tratamento de síndrome do x frágil com canabidiol |
| AU2022257344A1 (en) * | 2021-04-12 | 2023-10-26 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| EP4098254A1 (en) * | 2021-06-04 | 2022-12-07 | Assistance Publique, Hopitaux De Paris | Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease |
| JP2025535174A (ja) * | 2022-10-17 | 2025-10-22 | インベンテージ ラボ インコーポレイテッド | 炎症性疾患の治療または予防のための徐放型注射用組成物およびその製造方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9807639D0 (en) * | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
| US8449908B2 (en) * | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
| GB2414933B (en) * | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
| EP1890727B1 (en) * | 2005-05-25 | 2012-10-03 | CaloSyn Pharma, Inc | Method and composition for treating osteoarthritis |
| US20090247619A1 (en) * | 2008-03-06 | 2009-10-01 | University Of Kentucky | Cannabinoid-Containing Compositions and Methods for Their Use |
| CN102271705A (zh) * | 2008-12-22 | 2011-12-07 | 墨尔本大学 | 骨关节炎治疗 |
| CA2760460C (en) * | 2009-04-28 | 2019-04-02 | Alltranz Inc. | Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same |
| EP2424568A1 (en) * | 2009-04-29 | 2012-03-07 | University Of Kentucky Research Foundation | Cannabinoid-containing compositions and methods for their use |
| PT2473475T (pt) * | 2009-08-31 | 2017-08-02 | Zynerba Pharmaceuticals Inc | Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas |
| KR20150056522A (ko) * | 2012-06-26 | 2015-05-26 | 앰버데일 엔터프라이지즈 피티와이 리미티드 | 초음파 공동화에 의한 지방 조직으로부터 줄기 세포의 분리 및 이의 이용 방법 |
| EP3177286A4 (en) * | 2014-07-18 | 2018-05-16 | Medipath Inc. | Compositions and methods for physiological delivery using cannabidiol |
| JP2020530857A (ja) * | 2017-08-14 | 2020-10-29 | ジナーバ・ファーマシューティカルズ・インコーポレイテッド | 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 |
-
2018
- 2018-08-13 JP JP2020509441A patent/JP2020530857A/ja active Pending
- 2018-08-13 BR BR112020003025-2A patent/BR112020003025A2/pt unknown
- 2018-08-13 IL IL301622A patent/IL301622A/en unknown
- 2018-08-13 WO PCT/IB2018/056090 patent/WO2019034985A1/en not_active Ceased
- 2018-08-13 EP EP18846438.2A patent/EP3668500A4/en active Pending
- 2018-08-13 KR KR1020207005446A patent/KR20200054171A/ko not_active Ceased
- 2018-08-13 CA CA3072849A patent/CA3072849A1/en active Pending
- 2018-08-13 MX MX2020001768A patent/MX2020001768A/es unknown
- 2018-08-13 AU AU2018318425A patent/AU2018318425A1/en not_active Abandoned
- 2018-08-13 JO JOP/2020/0031A patent/JOP20200031A1/ar unknown
-
2020
- 2020-02-11 IL IL272593A patent/IL272593A/en unknown
- 2020-02-12 US US16/788,882 patent/US20200170963A1/en not_active Abandoned
-
2023
- 2023-05-29 JP JP2023087510A patent/JP7590803B2/ja active Active
- 2023-06-13 US US18/209,267 patent/US20240189255A1/en not_active Abandoned
- 2023-10-06 US US18/482,799 patent/US20240148669A1/en not_active Abandoned
-
2024
- 2024-08-15 AU AU2024205778A patent/AU2024205778A1/en active Pending
- 2024-11-12 JP JP2024197147A patent/JP2025024068A/ja active Pending
-
2025
- 2025-01-01 US US19/007,534 patent/US20250268843A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023109969A5 (https=) | ||
| JP2020530857A5 (https=) | ||
| CN103796651B (zh) | 脂肪酸组合物和植物提取物与药物制剂及其应用 | |
| CN101417060B (zh) | 一种治疗外伤、跌打、斑秃及烧烫伤的药膏 | |
| WO2016141219A1 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation | |
| CN104434740A (zh) | 一种中药祛痘凝胶剂及其制备方法 | |
| CN102205020A (zh) | 一种治疗跌打损伤的中药 | |
| CN103169822B (zh) | 滑膜炎回药膏及其制备方法 | |
| CN102872283A (zh) | 一种治疗骨折的中药组合物 | |
| CN102600256B (zh) | 一种用于跌打损伤中药组合物 | |
| CN102743587A (zh) | 一种外用创伤修复液 | |
| CN103316177B (zh) | 一种活血化瘀、消炎止痛膏及其制备方法 | |
| CN115105580A (zh) | 一种外用消肿镇痛的含神经酸的中药组合物及制备方法 | |
| CN104857000B (zh) | 一种治疗脚气的药物及其制备方法 | |
| CN100350921C (zh) | 一种去除皮肤病的药物 | |
| CN118286149B (zh) | 一种治疗风湿骨痛的组合物及其制备方法及其应用 | |
| US3171782A (en) | Oral compositions comprising lysozyme and vitamin b6 | |
| CN1332697C (zh) | 一种治疗结核病的中药 | |
| CN115969902B (zh) | 用于治疗寻常型银屑病的药物及其制备方法 | |
| CN1177592C (zh) | 红芪提取物总皂甙在制备治疗心肌炎药物中的应用 | |
| CN1994457B (zh) | 一种消肿止痛的外用膏药 | |
| CN108420877A (zh) | 一种治疗跌打损伤与消肿止痛中药制剂 | |
| CN101049363A (zh) | 一种肤痒剂的药物组合物及其制备方法 | |
| CN1279947C (zh) | 治疗跌打损伤的药物 | |
| CN120732995A (zh) | 一种中药透皮缓释止痛膏贴及其制备方法和应用 |